Event Participants
Executives
4 Maulik Patel, Milind Kotecha, Rakesh Agrawal, Kaushal Soparkar
Analysts
9 Abhinav Mandowara, Harshit Singhania, Maneesh Bhadane, Nirav Jimudia, Pratik Oza, Pujan Shah, Rohit Nagraj, Rohit Sinha, Sakshi Trivedi
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Revenue | ₹709 crores | +15% YoY from ₹615 crores in Q1 FY26; driven by higher sales volumes and improved realizations across diversified product basket |
| EBITDA | ₹179 crores | +10% YoY from ₹163 crores in Q1 FY26; absolute growth offset by margin compression |
| EBITDA Margin | 25% | -200 bps YoY from 27% in Q1 FY26; product mix shift and input cost volatility |
| PAT | ₹99 crores | +25% YoY vs adjusted PAT of ₹79 crores in Q1 FY26 (excludes ₹81 crore deferred tax gain in reported Q1 FY26) |
| ROCE | 16% | Down from 24% as on June 30, 2025; 18% excluding CWIP; decline due to lower trailing earnings and sizable capital work in progress |
| Net Debt/EBITDA | 0.8x | Up from 0.6x as on June 30, 2025; driven by lower trailing EBITDA and higher debt |
| Net Debt | ₹474 crores | Up from ₹439 crores as on June 30, 2025; capex spending of ₹62 crores in Q1 FY27 |
| Capex (Q1 FY27) | ₹62 crores | Ongoing capacity expansions for ECH and CPVC resin progressing on timeline and budget |
| Caustic Soda Utilization | ~75% | Reduced from prior quarters due to technical issues; domestic demand supported by alumina sector growth |
| ECH Utilization | ~70-75% | Capacity expansion to 100K TPA underway; 50% targeted for captive epoxy consumption |
| CPVC Utilization | ~50-55% | Impacted by PVC price volatility and inventory management by pipe manufacturers; seasonal monsoon weakness |
| Chloromethanes Utilization | ~100% | Running at full capacity |
| Peroxide Utilization | ~85-90% | Benefiting from high natural gas prices making competitor production costlier |
| ECU Realization (Q1 FY27) | ₹35,000-36,000 | Up from ₹30,000 in Q4 FY26; currently ₹31,000-32,000 post conflict cooling |
| Chlorine Realization | Negative ₹4,000 | Continued weak chlorine pricing environment |
| ECH Realization | ₹180-185/kg | Down from war-time peak of ₹200-210; low of ₹175; trending up to ₹185-190 |
| CPVC Realization | ₹110-115/kg | Ethylene-based PVC pricing already above MIP; limited direct impact from MIP on carbide-based PVC |
Geographic & Segment Commentary
Chlor-Alkali & Derivatives (Caustic Soda, Chlorine, Chloromethanes, Peroxide): Caustic utilization at 75% with ECU realizations of ₹35-36K in Q1 (currently ₹31-32K). Chlorine remains negative at ~₹4K. Chloromethanes at 100% utilization. Peroxide at 85-90% utilization benefiting from high gas prices disadvantaging competitors. Management expects structural caustic deficit in India due to alumina demand growth, absorbing new capacity over medium term.
Epichlorohydrin (ECH): Utilization 70-75% with realizations of ₹180-185/kg (down from ₹200-210 peak). Capacity expansion from 50K to 100K TPA underway. Strategic split: 50% captive consumption for epoxy resin, 50% merchant sales. Glycerin feedstock dynamics influenced by biodiesel mandates but palm oil pricing and logistics also key drivers.
CPVC Resin: Utilization 50-55% impacted by PVC volatility and pipe industry inventory management. Realizations ₹110-115/kg. Ethylene-based PVC (used by Epigral) already above MIP floor; MIP primarily affects carbide-based PVC. Management sees conversion of PVC applications to CPVC driving volume growth from Q3/Q4 FY27. New 75K TPA capacity coming online; near-term overcapacity risk from Grasim expansion but long-term demand positive.
Chlorotoluenes & Derivatives: Existing ₹250 crore capex targeting ₹300-350 crore revenue at optimum. New Multipurpose Plant (MPP) to produce photochlorination and cyanation derivatives for pharma/agro intermediates and water treatment chemicals. Pilot plant operational by September 2026 to accelerate customer approvals. Target: ₹500 crore revenue from MPP by FY29-30; combined chlorotoluenes + MPP potential ₹700-800 crore.
Epoxy Resin & Formulations (New): Board approved 125K TPA capacity with ₹600 crore combined capex (epoxy + MPP). >50% raw material value sourced internally (ECH, caustic). Pilot plant by Q2 FY27 for quality validation and customer trials. Target markets: windmill blades, automotive, construction, renewables, electronics. Peak revenue potential ₹1,300-1,500 crore (epoxy + MPP). Initial focus on basic LER, transitioning to specialty formulations. Export option to Europe post-FTA.
Company-Specific & Strategic Commentary
Forward Integration into Advanced Materials: Epigral is structurally integrating downstream into Epoxy Resin & Formulations and specialty chlorotoluene/ECH derivatives. The epoxy project leverages >50% internal raw material sourcing (ECH, caustic), creating cost advantage. MPP addresses import substitution for pharma/agro intermediates and water treatment chemicals. Both projects use pilot facility (operational Q2 FY27) to de-risk customer approval timelines.
Diversified Portfolio Resilience: Q1 FY27 demonstrated portfolio resilience amid West Asia conflict and shipping disruptions. While certain segments faced headwinds, alternative product lines offset impact, delivering 15% revenue growth. Management emphasizes diversification as key to consistent long-term growth across chemical cycles.
Renewable Energy Procurement Strategy: No further captive power plant investments. Energy requirements met via long-term solar/wind hybrid PPAs (20MW operational, 20MW contracted). Management claims cost parity with captive power plus regulatory advantages. Scalable approach for future expansions.
ECH Capacity Doubling with Captive-Offtake Discipline: Expansion to 100K TPA ECH capacity with explicit 50/50 split between captive epoxy consumption and merchant sales. Ensures continued supply to existing ECH customers while feeding forward integration. Merchant ECH realizations provide cash flow visibility.
Customer Approval De-risking via Pilot Plants: Learning from 2-year chlorotoluene approval delays, company invested in pilot facilities for both epoxy and MPP. Expected to validate product quality, optimize processes, and secure customer approvals ahead of commercial commissioning. Critical for specialty chemical stickiness.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Revenue CAGR (5-year) | 15-20% | Management internal target 20%+; driven by capacity ramp-ups (ECH, CPVC, chlorotoluenes, epoxy, MPP) and India demand growth across infrastructure, renewables, auto, pharma |
| EBITDA Margin (Post-Epoxy) | Lower % but higher absolute | Epoxy resin has 3-4x asset turnover vs current portfolio; margin % declines but absolute EBITDA and ROCE maintained. ROCE target ~20% for new projects |
| Capex FY27 | ₹400 crores | Ongoing ECH/CPVC expansions + epoxy/MPP pilot and early works |
| Capex FY28 | ₹400 crores | Peak spending for epoxy resin (125K TPA) and MPP commissioning |
| Capex Funding | 40% internal, 60% debt | Net debt/EBITDA expected to remain manageable; current 0.8x |
| MPP Revenue Milestone | ₹500 crores by FY29-30 | Gradual ramp-up post FY28 commissioning; specialty product approvals via pilot plant |
| Chlorotoluenes + MPP Peak Revenue | ₹700-800 crores | Includes existing ₹250 crore chlorotoluene capex (₹300-350 crore at optimum) + MPP |
| Epoxy + MPP Peak Revenue | ₹1,300-1,500 crores | Combined potential at full utilization; epoxy dominates volume |
| Tax Rate | ~25% | Normalized effective tax rate post deferred tax adjustments |
| ROCE Target (New Projects) | ~20% | Project evaluation hurdle rate; epoxy fits despite lower margin % due to high asset turnover |
Risks & Constraints
| Risk | Context |
|---|---|
| Geopolitical & Logistics Disruption | Ongoing West Asia conflict directly impacting raw material costs (glycerin, propylene, methanol) and finished goods pricing; shipping line disruptions causing transit delays and logistical constraints. Management expects stabilization but timing uncertain. |
| PVC Price Volatility & CPVC Margin Compression | PVC prices spiked to ₹84-85/kg post-MIP; CPVC realizations at ₹110-115/kg not yet reflecting full pass-through. Carbide-based PVC imports pressured by MIP but ethylene-based PVC (Epigral's feedstock) less affected. Near-term margin squeeze possible; management expects stabilization over full year. |
| Caustic Soda Oversupply Risk | Industry-wide capacity additions over past years; utilization dropped to 75%. Short-term demand-supply mismatch possible, but management argues structural deficit from alumina sector growth will absorb capacity over medium term. |
| ECH Realization Volatility | Prices swung from ₹175 to ₹210/kg in recent months driven by glycerin/propylene dynamics, crude oil, and logistics. Glycerin supply influenced by Indonesian biodiesel mandates (B50) and palm oil cycles. No long-term visibility; project economics based on pre-war normalized pricing. |
| CPVC Demand Weakness & New Competitor Capacity | Pipe industry inventory management and monsoon seasonality depressing volumes. Grasim's new CPVC capacity adding near-term supply pressure. Management acknowledges 1-2 year overcapacity but confident in India's |